文献速递泌尿生殖与妇科肿瘤放疗姑息放疗与转移瘤

p27与前列腺癌放疗后结局的关联:NRG/RTOG 8610和9202二次分析

The Association of p27 With Prostate Cancer Outcomes: A Secondary Analysis of NRG/RTOG 8610 and 9202.
PubMed 文献 · Adv Radiat Oncol · 2026-03-10

本研究基于两项随机III期试验NRG/RTOG 8610和9202的放疗前前列腺活检样本,用免疫组化及自动图像分析定量核p27,评估其与放疗±雄激素剥夺治疗(ADT)后结局的关联。结论认为证据不足以认定核p27是放疗±ADT患者的预后因素,观察到的趋势与前列腺切除术后文献方向相反。

要点

  • 核p27对放疗±ADT患者的预后价值证据不足,趋势与前列腺切除术后文献相反。

核心结论

  • 本研究证据不足以认定核p27水平是接受放疗±ADT的前列腺癌患者的预后因素。
  • 观察到的趋势与前列腺切除术后文献中低核p27负向预后的方向相反,提示放疗±ADT可能抵消该负向预后价值。

研究设计与样本

  • 对两项随机III期试验NRG/RTOG 8610和9202的放疗前前列腺活检样本进行二次分析,分析队列n=361。
  • 核p27用免疫组化检测、自动图像分析定量,按连续变量和分类变量(≤中位数 vs >中位数)分析。
  • 采用单因素和多因素Cox比例风险模型,主要结局为总生存,次要结局包括DSS、无病生存、远处转移和生化失败。

主要发现

  • 单因素分析中p27与总生存无关联。

关键数值与推荐

  • p27分类以中位数为界分为≤中位数与>中位数两组。

临床怎么用

  • 目前证据不支持将核p27作为放疗±ADT前列腺癌患者的预后分层指标。
  • p27在前列腺切除术后与放疗±ADT后预后方向可能不同,解读p27预后意义时需结合治疗方式。

局限性

  • 为二次分析,分析队列n=361,样本量有限。
  • 分类p27与DSS的关联未在连续变量分析中重现,且多因素分析无显著关联,结果稳健性不足。
  • 原文指出需进一步研究确认低核p27负向预后价值是否被放疗±ADT抵消的假设。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The cyclin-dependent kinase inhibitor p27 is a well-profiled modulator of cell cycle progression. Low nuclear p27 levels have been demonstrated to have a negative prognostic impact on outcomes in patients undergoing prostatectomy. The prognostic value of p27 after radiation therapy (RT) for prostate cancer is unknown. METHODS AND MATERIALS: Levels of p27 were evaluated in pre-RT prostate biopsy samples from 2 randomized, phase 3 trials, NRG/RTOG 8610 and 9202, which treated patients with RT with or without androgen deprivation therapy (ADT). Nuclear p27 was analyzed using immunohistochemistry and quantified using automated imaging analysis. The association of p27 as both a continuous and categorical measure (≤ median vs > median) with clinical outcome was estimated using both univariable (UVA) and multivariable Cox proportional hazards models. The primary clinical outcome measure was overall survival, and secondary measures were disease-specific survival (DSS), disease-free survival, distant metastases, and biochemical failure. RESULTS: In the analytical cohort (n = 361), no association of p27 with overall survival was observed on UVA. The only statistically significant association observed on UVA was between categorical p27 high levels and DSS (hazard ratio [HR] 1.57 [95% CI, 1.01-2.43], P = .044) in the combined cohort. However, a similar association was not observed with DSS when analyzing continuous p27 (P = .09). On multivariable analyses, no statistically significant association was observed between p27 and any evaluated clinical outcome measure (all P > .05). CONCLUSIONS: This study produced insufficient evidence to conclude that nuclear p27 level is prognostic of outcome in patients undergoing RT ± ADT. The observed trend was opposite in direction to the prior observations in the postprostatectomy literature, which served as a basis for this study. Given this, these data generate the hypothesis that the negative prognostic value of low nuclear p27 level in patients undergoing prostatectomy may be obviated by the receipt of RT ± ADT. Although this does appear congruent with known mechanistic differences between the two treatments, further studies are required to confirm this finding.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Patel KR, Pugh SL, Simko JP, et al. The Association of p27 With Prostate Cancer Outcomes: A Secondary Analysis of NRG/RTOG 8610 and 9202. Adv Radiat Oncol. 2026. PMID: 42006401. doi:10.1016/j.adro.2026.102022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。